AI Regulation will not undermine industry innovation – empirical examples of technology prove.
Heikkilä, 2021 - Politico’s AI Correspondent in London [Melissa, Politico March 31 “AI Decoded: NATO on AI warfare — AI treaty consultation — Unions call for more AI protections” https://www.politico.eu/newsletter/ai-decoded/politico-ai-decoded-nato-on-ai-warfare-ai-treaty-consultation-unions-call-for-more-ai-protections/ Acc 4/9/22 TA]
AI LAWS WHY REGULATION WON’T KILL INNOVATION: The Council of Europe, the Strasbourg-based human rights organization, is hard at work on a draft proposal on artificial intelligence. If ratified, the treaty could become national law in the group’s 47 member countries. AI: Decoded rang up Gregor Strojin, the chair of the group’s committee, called CAHAI, that’s drawing up the rules to hear the latest developments. The goal: CAHAI is working on an AI treaty with additional rules for specific sectors, such as social affairs and justice systems, and problems, like the discrimination of minorities. The plan is to have a draft ready by the end of they year, after which the Committee of Ministers — national representatives to the Council of Europe — will debate it. “In the past, there have been examples of treaties that were adopted in a matter of months. But sometimes it can take years. Sometimes it can be never. But I think we’re making a pretty strong point that in this case, delaying it could lead to irreparable damage,” Strojin said. “We are seeing increasing use of technologies that’s being imported from other parts of the world, without any risk assessment, without any impact assessment in a way that’s actually dumping the technology on certain countries,” he continued. Been there done that: Strojin also pushed back against industry jeremiads that regulation would “hamper innovation.” He said that AI regulators can actually learn a lot from past negotiations around pharmaceuticals and bioethics as an example of how regulation can help innovation. In 1964, the Council of Europe adopted the European Pharmacopoeia, which is the official standard and scientific basis for the quality control of pharmaceuticals. “Before that medical products and also services were like snake oil. There was no common assessment of what are the ingredients [or] what are the side effects of drugs,” Strojin said. (Sound familiar?) “I don’t think we have a problem with the lack of innovation in the pharmaceutical sector at this point,” Strojin said.